Filing Flows › Cartesian Therapeutics (RNAC) › How it makes money
How Cartesian Therapeutics (RNAC) makes money
Cartesian Therapeutics (RNAC) made $78K of revenue in the first quarter 2026 (Q1 2026), -93% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q1 2026 | % of revenue |
|---|---|---|
| Revenue | $78K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 2026 | $78K | -93% |
| Q4 2025 | $947K | — |
| Q3 2025 | $452K | +17% |
| Q2 2025 | $298K | -99% |
| Q1 2025 | $1.1M | -81% |
From Cartesian Therapeutics' 10-Q filed Apr 30, 2026 (on EDGAR).
Questions
How does Cartesian Therapeutics make money?
Cartesian Therapeutics (RNAC) made $78K of revenue in the first quarter 2026 (Q1 2026), -93% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.